Results 31 to 40 of about 18,080 (165)

Prevalence and predictors of kaposi sarcoma herpes virus seropositivity: a cross-sectional analysis of HIV-infected adults initiating ART in Johannesburg, South Africa

open access: yesInfectious Agents and Cancer, 2011
Background Kaposi sarcoma (KS) is the most common AIDS-defining tumour in HIV-infected individuals in Africa. Kaposi sarcoma herpes virus (KSHV) infection precedes development of KS.
Maskew Mhairi   +5 more
doaj   +1 more source

Application of the CDK9 inhibitor FIT-039 for the treatment of KSHV-associated malignancy

open access: yesBMC Cancer, 2023
Chronic infection with Kaposi’s sarcoma-associated herpes virus (KSHV) in B lymphocytes causes primary effusion lymphoma (PEL), the most aggressive form of KSHV-related cancer, which is resistant to conventional chemotherapy.
Tetsunori Sakamoto   +5 more
doaj   +1 more source

Pan‐gammaherpesvirus control via a broadly neutralising gB antibody [PDF]

open access: yesClin Transl Med
Clinical and Translational Medicine, Volume 16, Issue 9, September 2026.
Jiang Z, Li P, Xie C, Sun C.
europepmc   +2 more sources

Selected genes of Human herpesvirus-8 associated Kaposi's sarcoma among patients with Human Immunodeficiency Virus-1 and Acquired Immunodeficiency Disease Syndrome

open access: yesThe Pan African Medical Journal, 2019
INTRODUCTION: Kaposi's sarcoma (KS) is a kind of cancer that causes flat or raised lesions containing Human herpes virus 8 (HHV8). The KS lesions are common among immunosuppressed HIV patients.
Rodgers Norman Demba   +3 more
doaj   +1 more source

Seroprevalence and risk factors for Kaposi’s Sarcoma associated herpesvirus among men who have sex with men in Shanghai, China

open access: yesBMC Infectious Diseases, 2023
Background This study aimed to facilitate the understanding of the transmission route and risk factors that might contribute to the infection of Kaposi’s sarcoma associated herpesvirus (KSHV) among men who have sex with men (MSM).
Yi Li   +5 more
doaj   +1 more source

Prevalence and correlates of Kaposi’s sarcoma-associated herpesvirus and herpes simplex virus type 2 infections among adults: evidence from the NHANES III data

open access: yesVirology Journal, 2022
Background Kaposi’s sarcoma-associated herpes virus (KSHV) prevalence and risk factors exhibit considerable variations across populations in different geographic regions. Determinants and the transmission routes of KSHV infection are uncertain.
Xin Zhang   +5 more
doaj   +1 more source

KSHV-Mediated Regulation of Par3 and SNAIL Contributes to B-Cell Proliferation. [PDF]

open access: yes, 2016
Studies have suggested that Epithelial-Mesenchymal Transition (EMT) and transformation is an important step in progression to cancer. Par3 (partitioning-defective protein) is a crucial factor in regulating epithelial cell polarity. However, the mechanism
Darine W El-Naccache   +13 more
core   +1 more source

KSHV-mediated autophagy utilizes MK2.

open access: yes, 2023
A: HUVECs were transduced with recombinant lentiviruses expressing shRNAs targeting MK2 or a non-targeting control (NS) and selected with puromycin (1 μg/mL). After selection, transduced cells were infected with wild-type (WT) or delete KapB (delB) BAC16
Jennifer A. Corcoran (13297021)   +6 more
core   +1 more source

RNA Sequencing Reveals that Kaposi Sarcoma-Associated Herpesvirus Infection Mimics Hypoxia Gene Expression Signature.

open access: yesPLoS Pathogens, 2017
Kaposi sarcoma-associated herpesvirus (KSHV) causes several tumors and hyperproliferative disorders. Hypoxia and hypoxia-inducible factors (HIFs) activate latent and lytic KSHV genes, and several KSHV proteins increase the cellular levels of HIF.
Coralie Viollet   +7 more
doaj   +1 more source

Kaposin-B enhances the PROX1 mRNA stability during lymphatic reprogramming of vascular endothelial cells by Kaposi's sarcoma herpes virus. [PDF]

open access: yes, 2010
Kaposi's sarcoma (KS) is the most common cancer among HIV-positive patients. Histogenetic origin of KS has long been elusive due to a mixed expression of both blood and lymphatic endothelial markers in KS tumor cells.
Kafka, Darren   +37 more
core   +1 more source

Home - About - Disclaimer - Privacy